Efficacy relevance of PD-L1 expression on circulating tumor cells in metastatic breast cancer patients treated with anti-PD-1 immunotherapy

被引：0
|
作者：
Ying Zhou
Jinmei Zhou
Xiaopeng Hao
Haoyuan Shi
Xuejie Li
Anqi Wang
Zhiyuan Hu
Yanlian Yang
Zefei Jiang
Tao Wang
机构：
[1] Fujian Medical University,Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, Fujian Provincial Key Laboratory of Brain Aging and Neurodegenerative Diseases, School of Basic Medical Sciences
[2] CAS Center for Excellence in Nanoscience,CAS Key Laboratory of Standardization and Measurement for Nanotechnology, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety
[3] National Center for Nanoscience and Technology of China,Breast Cancer Department
[4] The Fifth Medical Center of Chinese PLA General Hospital,Department of General Surgery
[5] The Fifth Medical Center of Chinese PLA General Hospital,School of Nanoscience and Technology
[6] Sino-Danish College,School of Chemical Engineering and Pharmacy
[7] University of Chinese Academy of Sciences,undefined
[8] Wuhan Institute of Technology,undefined
[9] Anhui Medical University,undefined
[10] Southern Medical University,undefined
来源：
Breast Cancer Research and Treatment | 2023年 / 200卷
关键词：
Circulating tumor cells; Breast cancer; Programmed death-ligand 1; Programmed death-1; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：281 / 291
页数：10
相关论文
共 50 条
  • [21] Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
    Lucia Festino
    Gerardo Botti
    Paul Lorigan
    Giuseppe V. Masucci
    Jason D. Hipp
    Christine E. Horak
    Ignacio Melero
    Paolo A. Ascierto
    [J]. Drugs, 2016, 76 : 925 - 945
  • [22] PD-L1 expressing circulating tumor cells (CTCs) in patients with breast cancer
    Zavridou, Martha
    Strati, Areti
    Malamos, Nikos
    Georgoulias, Vasilis
    Lianidou, Evi S.
    [J]. CANCER RESEARCH, 2016, 76
  • [23] PD-L1 Copy Number Variation Does Not Correlate With PD-L1 Expression or Response to Anti-PD-1 Immunotherapy In Patients With Advanced Melanomas
    Perottet, Jeremy
    Le Goff, Emeline
    Legoupil, Delphine
    Quere, Gilles
    Schick, Ulrike
    Marcorelles, Pascale
    Uguen, Arnaud
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (02) : 161 - 165
  • [24] Isolation of circulating tumor cells and evaluation of PD-L1 expression in metastatic lung cancer
    Dhar, Manjima
    Che, James
    Wong, Jessica M.
    Pao, Edward
    Yu, Victor S. H.
    Matsumoto, Melissa
    Goldman, Jonathan
    Garon, Edward
    Sollier, Elodie
    Kulkarni, Rajan
    Di Carlo, Dino
    [J]. CANCER RESEARCH, 2015, 75
  • [25] PD-L1 expression on circulating monocytes in patients with breast cancer
    Nagano, M.
    Saito, K.
    Kozuka, Y.
    Shibusawa, M.
    Imai, N.
    Noro, A.
    Kageyama, Y.
    Mizuno, T.
    Ogawa, T.
    Katayama, N.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [26] Efficacy of anti-PD-1 antibodies in NSCLC patients with an EGFR mutation and high PD-L1 expression
    Ken Masuda
    Hidehito Horinouchi
    Midori Tanaka
    Ryoko Higashiyama
    Yuki Shinno
    Jun Sato
    Yuji Matsumoto
    Yusuke Okuma
    Tatsuya Yoshida
    Yasushi Goto
    Noboru Yamamoto
    Yuichiro Ohe
    [J]. Journal of Cancer Research and Clinical Oncology, 2021, 147 : 245 - 251
  • [27] Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung Cancer
    Shukuya, Takehito
    Carbone, David P.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : 976 - 988
  • [28] Optimizing the Treatment Schedule of Radiotherapy Combined With Anti-PD-1/PD-L1 Immunotherapy in Metastatic Cancers
    Kong, Yuehong
    Ma, Yifu
    Zhao, Xiangrong
    Pan, Jie
    Xu, Zhi
    Zhang, Liyuan
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [29] Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1
    Champiat, Stephane
    Dercle, Laurent
    Ammari, Samy
    Massard, Christophe
    Hollebecque, Antoine
    Postel-Vinay, Sophie
    Chaput, Nathalie
    Eggermont, Alexander
    Marabelle, Aurelien
    Soria, Jean-Charles
    Ferte, Charles
    [J]. CLINICAL CANCER RESEARCH, 2017, 23 (08) : 1920 - 1928
  • [30] Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1/PD-L1 agents: A meta-analysis
    Abdel-Rahman, Omar
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 101 : 75 - 85
12345